Abstract: The present invention discloses oral compositions for nourishment of a mammalian subject which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. These compositions, being highly palatable, increase consumption of said composition, further configured to decrease mortality rate, increase weight gain, reduced use of either antibiotics or milk replacers and improve small intestine anatomy of said mammalian.

Abstract: The present invention discloses oral isotonic compositions to provide hydration to mammals in need, comprising a prebiotic oligosaccharide or fructo-oligosaccharide and at least three members of the group consisting of steviol glycoside, citric acid monohydrate, glutamic acid, monosodium glutamate and glycine.

Abstract: The present invention discloses methods and compositions for nourishing newly-borne mammals; specifically, reducing antibiotic usage, increasing weight and increasing immunoglobulin concentrations in said newly borne mammals, following oral treatment of pregnant mammals of said newly-borne mammals. The compositions of the current invention have chicken, beef, fish or apple flavouring.

Abstract: The present invention discloses palatable oral formulations for hydrating, supporting gut activity, micronutrient supplementation and providing oral carriers for vaccines, antibiotics and food supplements, of inter alia, companion or pet animals.

Abstract: The present invention discloses oral isotonic compositions to provide hydration to mammals in need, characterized by no residual chlorine taste, comprising at least three members of a group consisting of steviol glycoside, citric acid monohydrate, glutamic acid, monosodium glutamate and glycine.

Abstract: The present invention discloses compositions which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. Furthermore, the invention provides diets, nutraceuticals and nutrition oral rehydration therapy, means and methods useful in treating and inducing of remission of inflammation in IBD patients.

Abstract: An oral rehydration composition comprising the following: 1-glutamic acid in a range of about 0.01% to about 0.40% w/w and monosodium glutamate in a range of about 0.05% to about 0.80% w/w; about 1.50% w/w glucose monohydrate; about 0.20% w/w sodium chloride; about 0.15% w/w potassium chloride; about 0.35% w/w glycine; about 0.30% w/w trisodiumcitrate; about 0.15% w/w sodium dihydrogen phosphate; about 0.10% w/w xanthan gum; 85% Steviol Glycoside extract in a range of about 0.01% to about 0.03% w/w; about 0.20% w/w citric acid monohydrate; hydrolyzed whey in a range of about 0.15% to about 1.00% w/w; about 1.00% w/w hydrolyzed wheat; comprises cereals as a protein source; comprises enzyme co-factors; comprises a monosaccharide. The oral rehydration composition can be used on humans or animals that suffer from diarrhea.

Abstract: An oral rehydration composition comprising the following: 1-glutamic acid in a range of about 0.01% to about 0.40% w/w and monosodium glutamate in a range of about 0.05% to about 0.80% w/w; about 1.50% w/w glucose monohydrate; about 0.20% w/w sodium chloride; about 0.15% w/w potassium chloride; about 0.35% w/w glycine; about 0.30% w/w trisodiumcitrate; about 0.15% w/w sodium dihydrogen phosphate; about 0.10% w/w xanthan gum; 85% Steviol Glycoside extract in a range of about 0.01% to about 0.03% w/w; about 0.20% w/w citric acid monohydrate; hydrolyzed whey in a range of about 0.15% to about 1.00% w/w; about 1.00% w/w hydrolyzed wheat; comprises cereals as a protein source; comprises enzyme co-factors; comprises a monosaccharide. The oral rehydration composition can be used on humans or animals that suffer from diarrhea.

Abstract: The present invention discloses oral compositions for nourishment a mammalian subject which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. These compositions, being highly palatable, increase consumption of said composition, further configured to decrease mortality rate, increase weight gain, reduced use of either antibiotics or milk replacers and improve small intestine anatomy of said mammalian.

Abstract: The present invention discloses compositions which comprises steviol glycoside, citric acid monohydrate, monosodium glutamate and/or glycine. Furthermore, the invention provides diets, nutraceuticals and nutrition oral rehydration therapy, means and methods useful in treating and inducing of remission of inflammation in IBD patients.

Abstract: An oral rehydration composition comprising the following: 1-glutamic acid in a range of about 0.01% to about 0.40% w/w and monosodium glutamate in a range of about 0.05% to about 0.80% w/w; about 1.50% w/w glucose monohydrate; about 0.20% w/w sodium chloride; about 0.15% w/w potassium chloride; about 0.35% w/w glycine; about 0.30% w/w trisodiumcitrate; about 0.15% w/w sodium dihydrogen phosphate; about 0.10% w/w xanthan gum; 85% Steviol Glycoside extract in a range of about 0.01% to about 0.03% w/w; about 0.20% w/w citric acid monohydrate; hydrolyzed whey in a range of about 0.15% to about 1.00% w/w; about 1.00% w/w hydrolyzed wheat; comprises cereals as a protein source; comprises enzyme co-factors; comprises a monosaccharide. The oral rehydration composition can be used on humans or animals that suffer from diarrhea.

Abstract: Apparatus 30 for production of food products, which apparatus 30 comprises a feed section 40 and a compression section 41, the feed section 40 comprising open channels 50 into which food for processing is introduced by a plurality of regulating helixes 70 and drive elements 51 in the channels 50 for moving the food along the channels 50, the compression section 41 lying adjacent the feed section 40 such that food is moved by the drive elements 51 from the channels 50 into the compression section 41, the compression section 41 comprising tubes 66 of desired cross-section and length, whereby in use food is moved along the channels 50 and into the compression section 41 by the drive elements 51, subjected to a desired compression in the compression section 41 and then leaves the compression section 41 at the end thereof remote from the feed section 40. Improved quality food products can thereby be provided.

Abstract: Apparatus 30 for production of food products, which apparatus 30 comprises a feed section 40 and a compression section 41, the feed section 40 comprising open channels 50 into which food for processing is introduced by a plurality of regulating helixes 70 and drive elements 51 in the channels 50 for moving the food along the channels 50, the compression section 41 lying adjacent the feed section 40 such that food is moved by the drive elements 51 from the channels 50 into the compression section 41, the compression section 41 comprising tubes 66 of desired cross-section and length, whereby in use food is moved along the channels 50 and into the compression section 41 by the drive elements 51, subjected to a desired compression in the compression section 41 and then leaves the compression section 41 at the end thereof remote from the feed section 40. Improved quality food products can thereby be provided.

Abstract: A solid food composition, preferably a ready-to-eat cereal composition, which provides for the release of energy over an extended period of time. The solid food composition includes: (a) from about 20% to about 55% by weight of a low fiber, high degree of cook, fraction; (b) from about 20% to about 40% by weight of a medium fiber, medium degree of cook, fraction; and (c) from about 20% to about 45% by weight of a high fiber, low degree of cook, fraction; wherein the solid food composition includes at least about 20% by weight of an oat source selected from the group consisting of rolled oats or oat flour, and wherein the oat source is provided by one or more of the fractions.